about
Role of GABAB receptor in alcohol dependence: Reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholicsImprovement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial.A case of marked cerebellar atrophy in a woman with anorexia nervosa and cerebral atrophy and a review of the literature.Regional cerebral hypoperfusion in patients with celiac disease.Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study.Psychosocial findings in alcohol-dependent patients before and after three months of total alcohol abstinence.A human laboratory pilot study with baclofen in alcoholic individualsAlpe adria report 2010 - conclusions and recommendations for the treatment of alcohol dependence.How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review.Primary renal angiosarcoma: a rare malignancy. A case report and review of the literature.Baclofen: a new drug for the treatment of alcohol dependence.Elastography assessment in patients with chronic HCV infection.Serotonin transporter (SERT) brain density and neurobiological Cloninger subtypes model: a lesson by human autoradiography studies.Intestinal malabsorption and skin diseases.Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving.Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infectionBaclofen in the treatment of persistent hiccup: a case series.Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center.Management of alcohol dependence in patients with liver disease.Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options.Acute alcohol intoxication.Phytotherapeutic approach to alcohol dependence: new old way?Hormones and drinking behaviour: new findings on ghrelin, insulin, leptin and volume-regulating hormones. An ESBRA Symposium report.Understanding and treating patients with alcoholic cirrhosis: an update.Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update.Celiac disease: from gluten to skin.Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence.Role of feeding-related pathways in alcohol dependence: A focus on sweet preference, NPY, and ghrelin.Pharmacological management of alcohol dependence: from mono-therapy to pharmacogenetics and beyond.Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention.Interaction of alcohol intake and cofactors on the risk of cirrhosis.Role of the GABA(B) receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives.Social phobia in coeliac disease.Insulin but not insulin growth factor-1 correlates with craving in currently drinking alcohol-dependent patients.Brugada electrocardiographic findings in an 80-year-old man.Alcoholic Hepatitis and Liver Transplantation: The Good News and What to Do about It.Suppression of alcohol delirium tremens by baclofen administration: a case report.Multivariate identification of metabolic features in inflammatory bowel disease.New advances in addiction medicine.Nutritional status and body fluid distribution in chronic alcoholics compared with controls.
P50
Q29395989-480F1A21-2996-44F9-8805-EBDD2C6224E5Q30446318-234E0A6A-AE22-44F7-8797-F335361111CAQ31976096-4698B0DA-FFBD-4A7C-AACE-057049AD4250Q34301131-30365004-E4AE-4376-9CEB-D00DB55FBF4DQ34580892-75414A2A-6E2A-49CE-8196-349F0C669454Q34689478-23D20CA6-D91A-409A-84A4-B0B2BB46F45FQ34871492-076ECA65-5AFB-47CA-8277-39AA3B52563BQ35505858-9E052B41-9EA2-40D6-9284-94AF7AC2CA0CQ36059288-D92F4564-17B6-4ED5-97B4-A8E0D2F5A838Q36526261-6CA4961C-EA93-4BEB-A1F1-6B83EC019620Q36558764-8C5B35EE-64B0-4503-A4C8-DBC353A440EAQ37056707-F2E14C5D-2646-4E50-9CEA-5E326E208302Q37062596-738216C9-652C-4840-86B7-5D5A7D801922Q37145693-1D6EB86C-CA68-4313-A274-590539F1976AQ37153644-CEFE4053-9A2F-4034-83C1-3EC8C1F2C15BQ37156172-FB08810E-A787-4A79-8589-82F2E7AE6E33Q37157955-9C3CB1BE-DCED-4F45-98AE-0A8009BF4B14Q37158911-FC74A429-60AE-4814-97CD-B7B2BD629820Q37165425-5167397A-6F81-4811-8C64-869858CD4833Q37207786-6340973F-B4AD-4CB8-A0D7-5F33FA7C5C5FQ37338549-5F3B8D2C-D52D-4977-BA07-FDF0A389DFCEQ37392625-E358A73C-E296-49BA-9CC3-C4926ABAF457Q37423340-E3233BA3-31B2-4C5F-9489-51128A22421FQ37457162-9AA17F2A-747B-4474-873E-A9F6A6B31378Q37604844-34C57B0F-42F3-4FC1-BC1E-61E80EA3422BQ37755338-0E4C40F7-716F-4915-B823-A60CD6F20753Q37756202-94ACB319-7C3C-425F-AEEB-FF6C9D7832C6Q37807998-003C6671-0528-44E5-9383-CE425E6DA02DQ38158467-8D2B43FD-29C1-4DD9-AE89-636AFB506636Q38166827-8A3D5005-7D74-4B80-AB9E-36948058B8A7Q39494191-5B7E65D3-F568-4DF1-A1B1-E3BCB2EEE3C1Q39929318-D7F9CBA3-DB97-4751-8BDD-578257F66262Q40110517-C403E275-1BC3-4B84-A0FA-A360E606967EQ40131852-DCAEF6E3-311B-4A35-ACDA-3FE0AF690757Q40240391-6DBDE10F-AB2E-44E9-9ED5-0CC946A1CD3CQ40257367-2D83F78C-862B-4F80-91D4-0222BA29B8D7Q40558892-E4A21545-FF04-4A4F-A676-EBE9E1D67A0BQ41686763-10FEE136-0D47-40FD-AD86-5D3610D6526AQ42011795-23B7B914-217F-4712-85EF-94989078235EQ42476074-23B13EFE-7F69-415B-BA5F-7445BD35B312
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanni Addolorato
@ast
Giovanni Addolorato
@en
Giovanni Addolorato
@es
Giovanni Addolorato
@nl
Giovanni Addolorato
@sl
type
label
Giovanni Addolorato
@ast
Giovanni Addolorato
@en
Giovanni Addolorato
@es
Giovanni Addolorato
@nl
Giovanni Addolorato
@sl
prefLabel
Giovanni Addolorato
@ast
Giovanni Addolorato
@en
Giovanni Addolorato
@es
Giovanni Addolorato
@nl
Giovanni Addolorato
@sl
P106
P1153
7006562766
P21
P31
P496
0000-0002-1522-9946